Acetylation of γ-mangostin Isolated from the Mangosteen Pericarp (Garcinia mangostana Linn.) and Their Antidiabetic Activity
Abstract
Keywords
Full Text:
PDFReferences
P. C. M. Jansen, J. Jukema, L. P. A. Oyen, and T. G. van Lingen, “Minor Edible Fruits and Nuts,” in Edible Fruits and Nuts, E. W. M. Verheij and R. F. Coronel, Eds. Bogor, Indonesia: Plants Resources of South-East Asia (PROSEA), 1991, pp. 175–177.
N. Noor, “Garcinia celebica,” in Timber Trees: Lesser-Known Timber, Bogor, Indonesia: Plants Resources of South-East Asia (PROSEA), 1998, pp. 246–249.
T. Uji, “Keanekaragaman, persebaran, dan potensi jenis-jenis Garnicia di Indonesia,” Berk. Penelit. Hayati, vol. 12, no. 2, pp. 129–135, 2007.
J. Pedraza-Chaverri, N. Cárdenas-Rodríguez, M. Orozco-Ibarra, and J. M. Pérez-Rojas, “Medicinal properties of mangosteen (Garcinia mangostana),” Food Chem. Toxicol., vol. 46, no. 10, pp. 3227–3239, 2008, doi: 10.1016/j.fct.2008.07.024.
A. P. Sari, “Senyawa α dan γ-mangostin dari Kulit Buah Garcinia mangostana L,” Institut Teknologi Sepuluh Nopember, 2011.
S. Fatmawati, T. Ersam, and K. Shimizu, “The inhibitory activity of aldose reductase in vitro by constituents of Garcinia mangostana Linn,” Phytomedicine, vol. 22, no. 1, pp. 49–51, 2015, doi: 10.1016/j.phymed.2014.11.001.
B. Vongsak, S. Kongkiatpaiboon, S. Jaisamut, S. Machana, and C. Pattarapanich, “In vitro alpha glucosidase inhibition and free-radical scavenging activity of propolis from Thai stingless bees in mangosteen orchard,” Rev. Bras. Farmacogn., vol. 25, no. 5, pp. 445–450, 2015, doi: 10.1016/j.bjp.2015.07.004.
World Health Organization, “Global report on diabetes,” 2016. http://www.who.int/diabetes/global-report/en/.
American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 37, no. SUPPL.1, pp. S81–S90, 2014, doi: 10.2337/dc14-S081.
World Health Organization (WHO), Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications. Geneva, Switzerland: WHO Press, 1999.
S. Surya, A. D. Salam, D. V. Tomy, B. Carla, R. A. Kumar, and C. Sunil, “Diabetes mellitus and medicinal plants-a review,” Asian Pacific J. Trop. Dis., vol. 4, no. 5, pp. 337–347, 2014, doi: 10.1016/S2222-1808(14)60585-5.
G. Zhou et al., “Role of AMP-activated protein kinase in mechanism of metformin action,” J. Clin. Invest., vol. 108, no. 8, pp. 1167–1174, 2001, doi: 10.1172/JCI13505.
R. R. Holman, “Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective,” Metabolism., vol. 55, no. SUPPL. 1, pp. S2–S5, 2006, doi: 10.1016/j.metabol.2006.02.006.
S. K. Morcos and H. S. Thomsen, “European Society of Urogenital Radiology guidelines on administering contrast media,” Abdom. Imaging, vol. 28, no. 2, pp. 187–190, 2003, doi: 10.1007/s00261-001-0186-5.
L. Jackson and L. Robertson, “Sulphonylureas (specifically glibenclamide) and their correct dosage,” South African Med. J., vol. 76, no. 6, 1989.
G. I. Varughese, A. A. Tahrani, and J. H. B. Scarpello, “The long and short of metformin-related vitamin B12 deficiency,” Arch. Intern. Med., vol. 167, no. 7, pp. 729–730, 2007, doi: 10.1001/archinte.167.7.729-b.
R. Z. W. Ting, C. C. Szeto, M. H. M. Chan, K. K. Ma, and K. M. Chow, “Risk factors of vitamin B12 deficiency in patients receiving metformin,” Arch. Intern. Med., vol. 166, no. 18, pp. 1975–1979, 2006, doi: 10.1001/archinte.166.18.1975.
K. Y. Kim, K. A. Nam, H. Kurihara, and S. M. Kim, “Potent α-glucosidase inhibitors purified from the red alga Grateloupia elliptica,” Phytochemistry, vol. 69, no. 16, pp. 2820–2825, 2008, doi: 10.1016/j.phytochem.2008.09.007.
M. M. Mojtahedi and S. Samadian, “Efficient and rapid solvent-free acetylation of alcohols, phenols, and thiols using catalytic amounts of sodium acetate trihydrate,” J. Chem., vol. 2013, 2013, doi: 10.1155/2013/642479.
Y. Ren et al., “Cytotoxic and NF-κB inhibitory constituents of the stems of Cratoxylum cochinchinense and their semisynthetic analogues,” J. Nat. Prod., vol. 74, no. 5, pp. 1117–1125, 2011, doi: 10.1021/np200051j.
Y. Liu, L. Zou, L. Ma, W. H. Chen, B. Wang, and Z. Le Xu, “Synthesis and pharmacological activities of xanthone derivatives as α-glucosidase inhibitors,” Bioorganic Med. Chem., vol. 14, no. 16, pp. 5683–5690, 2006, doi: 10.1016/j.bmc.2006.04.014.
S. Fatmawati, K. Shimizu, and R. Kondo, “Ganoderol B: A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum,” Phytomedicine, vol. 18, no. 12, pp. 1053–1055, 2011, doi: 10.1016/j.phymed.2011.03.011.
S. R. Ayinampudi, R. Domala, R. Merugu, S. Bathula, and M. R. Janaswamy, “New icetexane diterpenes with intestinal α-glucosidase inhibitory and free-radical scavenging activity isolated from Premna tomentosa roots,” Fitoterapia, vol. 83, no. 1, pp. 88–92, 2012, doi: 10.1016/j.fitote.2011.09.018.
DOI: http://dx.doi.org/10.12962/j23546026.y2020i6.9185
Refbacks
- There are currently no refbacks.
View my Stat: Click Here
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.